According to a recent LinkedIn post from Midas, the company is highlighting the launch of mRe7ETH, a tokenized version of Re7 Labs’ ETH Yield Strategy on the Optimism (OP) Mainnet, created in partnership with Re7 Capital. The post describes the strategy as market-neutral and targeting ETH-denominated returns, while emphasizing that Re7 Labs acts as strategy manager and that the Optimism Foundation is providing initial seeding capital.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The LinkedIn post underscores that mRe7ETH is a complex, high-risk DeFi-linked product with exposure to smart contract, market, protocol, and liquidity risks, and notes that investors could lose some or all of their capital. For investors, the initiative suggests Midas is deepening its presence in tokenized yield products and the DeFi ecosystem, which could expand its addressable market but also increases regulatory, technical, and reputational risk tied to performance, protocol security, and broader crypto-asset volatility.